ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.04
0.60%
US Tech 100
17,446.00
2.17%
S&P 500
5,127.79
1.26%
US Dollar vs CAD
1.36685
-0.02%
Bitcoin
63,686.83
1.28%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Theratechnologies Inc (THTX)

  7. Theratechnologies Inc (THTX) News

THTX Theratechnologies Inc

1.28
-0.06 (-4.48%)
May 03 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Theratechnologies Inc THTX NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
-0.06 -4.48% 1.28 17:39:15
Open Price Low Price High Price Close Price Previous Close
1.31 1.27 1.32 1.28 1.34
more quote information »

Recent News

Date Time Source Heading
5/02/202406:30GLOBETheratechnologies to Present Long-Term Efficacy, Safety and..
4/15/202415:15GLOBETheratechnologies Announces Mailing of Management Proxy..
4/11/202406:30GLOBETheratechnologies to Present at the 2024 Bloom Burton & Co...
4/10/202406:30GLOBETheratechnologies Reports Financial Results and Provides..
4/10/202406:15IHMARKETNEWSU.S. Index Futures Show Mixed Trend Ahead of Key Inflation..
4/08/202415:30GLOBETheratechnologies Preclinical Data Presentation at AACR 2024..
4/05/202410:00GLOBETheratechnologies Appoints Elina Tea to its Board of..
4/03/202406:30GLOBETheratechnologies to Announce First Quarter 2024 Financial..
3/28/202406:30GLOBETheratechnologies to Present Preclinical Data at AACR on..
3/22/202408:36GLOBETheratechnologies Announces Update on its Preclinical..
3/21/202419:00GLOBETheratechnologies Appoints Jordan Zwick to its Board of..
3/21/202406:30GLOBETheratechnologies Initiates Increased Dose Level in Phase 1..
2/29/202415:55EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2/29/202415:34GLOBETheratechnologies Announces the Resignation of One of Its..
2/27/202407:37EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2/27/202406:30GLOBETheratechnologies Receives Refusal to File Letter for..
2/21/202407:01EDGAR2Form 20-F - Annual and transition report of foreign private..
2/21/202407:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2/21/202406:30GLOBETheratechnologies Reports Financial Results for the Fourth..
2/20/202406:30GLOBETheratechnologies Announces Publication in Frontiers in..
2/15/202407:36EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2/15/202406:30GLOBETheratechnologies Completes Enrollment of First Six Patients..
2/06/202413:29EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2/06/202406:30GLOBETheratechnologies to Announce Fourth Quarter and Full Year..
2/01/202410:50EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
1/24/202412:52EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
1/24/202406:00GLOBETheratechnologies Receives Complete Response Letter (CRL)..
1/23/202413:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
1/23/202406:30GLOBETheratechnologies Receives Update from FDA on Tesamorelin F8..
1/03/202423:15EDGAR2Form EFFECT - Notice of Effectiveness
1/02/202415:28EDGAR2Form F-3/A - Registration statement by foreign private..
1/02/202408:00APSWill This Dual-Listed Bio-Pharma Catch New Year Action?
1/02/202406:30GLOBETheratechnologies Submits sBLA for Trogarzo® Intramuscular..
12/21/202315:24EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/21/202315:12PRNCATheratechnologies annonce le renouvellement de son..
12/21/202315:09PRNCATheratechnologies Announces Renewal of Shelf Prospectus and..
12/21/202312:21EDGAR2Form F-3 - Registration statement by foreign private issuers
12/13/202313:41EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/13/202306:30GLOBETheratechnologies Announces FDA Approval of Trogarzo®..
11/28/202315:52EDGAR2Form SC 13D - General statement of acquisition of beneficial..
11/24/202306:30GLOBETheratechnologies Receives 2023 CQDM ADRIQ RSRI Innovation..
11/06/202312:17EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/06/202311:28EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/03/202313:26EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/31/202311:51EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/31/202311:34GLOBETheratechnologies Announces Closing of US$25 Million Public..
10/26/202320:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/26/202308:50EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/26/202307:00GLOBETheratechnologies Announces Pricing of US$25 Million Public..
10/25/202315:13GLOBETheratechnologies Announces Proposed Public Offering of..

Your Recent History

NASDAQ
THTX
Theratechnologies
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved